The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer
Michalina Janiszewska(Scripps Research Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Otto Metzger(Dana-Farber Cancer Institute), Joe W. Gray(University of Newcastle Australia), Anne Trinh(Brigham and Women's Hospital), Ian E. Krop(Yale Cancer Center), Natalie L. Kingston(Dana-Farber Cancer Institute), Koei Chin(Oregon Health & Science University), Nicholas W. Harper(Dana-Farber Cancer Institute), Hege G. Russnes(Oslo University Hospital), Paul T. Spellman(Oregon Health & Science University), Maša Alečković(Princeton University), Benjamin Oakes(Dana-Farber Cancer Institute), Elisabetta Marangoni(Institut Curie), Shayna Stein(Harvard University), Jennifer Eng(Oregon Health & Science University), Eric P. Winer(University of Vermont), Katherine C. Murphy(Dana-Farber Cancer Institute), Simona Cristea(Harvard University), Franziska Michor(Dana-Farber Cancer Institute), Inga Hansine Rye(Oslo University Hospital), Zhi Hu(Oregon Health & Science University), Elmar Bucher(Brigham and Women's Hospital)
Cited by 42
Related Papers
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k